Login

Fubo CEO David Gandler discusses the company's 4Q earnings and the competitive landscape of sports streaming with Diane King Hall. 00:10:00

Share On Facebook Share On Twitter

David Gandler is Co-founder and CEO of FuboTV Inc.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
The Critical Need for Historical Knowledge in Military Strategy
00:10:00
GameStop Market Update: Unpacking the Latest Developments | Morgan Christen, CEO, Spinnaker Investment Group, LLC.
00:10:00
Fixed Income Investment Principles: Insights from Vivek Prabhu, Deputy Head of Credit and Fixed Income at Perpetual Investments
00:10:00
Perion Network CEO Tal Jacobson joins Nicole Petallides to discuss the company's role in major digital advertising channels.
00:10:00
The Global Venture Market will the VC funding decline stifle innovation|Amy Cheetham,Partner,Costanoa Ventures
00:10:00
InPost CEO Rafał Brzoska: Insights from Executive Summit 2022 Interview with Richard Quest | Rafał Brzoska - CEO of InPost SA
00:10:00
The Future of Bond Investing: Credit Selection Strategies with Columbia Threadneedle
00:10:00
Vantea Smart’s Growth Unveiled at INTEGER SIM Investor Day with Simone Veglioni | Simone Veglioni, CEO , Vantea Smart SPA.
00:10:00
Wilbur Ross on Microsoft's Antitrust Battle and Trade Relations with China | Wilbur Ross, Chairman , WL Ross & Co.
00:10:00
Exploring Innovations in Learning and Curriculum Development
00:10:00
Insights into AORA Biosurgery's innovative soft tissue reconstruction products, growth trajectory, and clinical trials |Brian Ward, CEO, Aroa Biosurgery Ltd .
00:10:00
Navigating Economic Challenges: Insights from Dr. Peter R. Orszag | Peter Orszag - Chief Executive Officer at Lazard Asset Management

© 2017 - Neuhu+